School of Chemistry
Booker-Milburn Group



News

 

News


15.09.16

New paper - A Small Footprint, High Capacity Flow Reactor for UV Photochemical Synthesis on the Kilogram Scale in Organic Process Research and Development. DOI

11.07.16

New paper - Real-Time Biological Annotation of Synthetic Compounds in Journal Of The American Chemical Society. DOI

06.07.16

New paper - Unusually Facile Thermal Homodienyl-[1,5]-Hydrogen Shift Reactions in Photochemically Generated Vinyl Aziridines in Chemistry - A European Journal. DOI

01.07.16

Beth Glaisyer has joined the group.

10.01.16

Congratulations to Dr. Michael Robertson-Ralph for passing his Viva!

Dr. Michael Robertson-Ralph has also recieved funding for a Post-Doctoral researcher position within the group

14.04.15

New paper - A Palladium(II)-Catalyzed C-H Activation Cascade Sequence for Polyheterocycle Formation published in Angewandte Chemie DOI

09.04.15

Congratulations to Dr. Stephen Cooper for passing his Viva!

04.03.15

Congratulations to Dr. Katie Maskill for passing her Viva!

26.01.15

New paper Electrocyclic Opening of Cyclobutene-Fused Bicyclic Systems published in Angewandte Chemie DOI

23.01.15

Mike Watt wins a prize for his poster presentation at the Catalytic C-H functionalization symposium at the University of Leicester.

05.01.15

Dr. Anna Tsoukala has joined the group.

26.09.14

New paper comparing batch and flow photochemistry published in Chemistry - A European Journal DOI

14.07.14

Robert Heap joined the group as a Post-Doctoral Researcher.

09.06.14

Thomas Nunns and Will Yu joined the group.

10.04.14

Rickki Connelly passed his viva. Congratulations Dr. Connelly!

27.03.14

Nick Barron passed his viva. Congratulations Dr. Barron!

01.10.13

Callum Stacey and Mike Watt join the group.

05.06.13

Emma Blackham joins the group!

07.01.13

Dr Paul Koovits joins the group as a new Post-Doctoral Researcher.

01.08.12

KBM officially welcomes Nick Barron to the group.

21.06.12

Dr Joe Wrigglesworth has passed his PhD viva! Congratulations!

23.01.12

A modified version of our original FEP Photochemical Flow Reactor (DOI) has been used by Seeberger & Levesque in a stunning continuous-flow synthesis of the front-line anti-malaria drug Artemisinin (DOI). As reported the complete integrated flow system can synthesize more the 200 g per day of this life saving drug and 400 such reactor systems could provide the current world's supply of Artemisinin required to treat the disease.